An approach to "middle molecules" identification in artificial kidney dialysate, with reference to neuropathy prevention.
D000818:Animals; D002460:Cell Line; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D003404:Creatinine / Q000097:blood; D005260:Female; D005347:Fibroblasts; D005374:Filtration; D005399:Fishes; D005612:Freeze Drying; D006801:Humans; D007688:Kidneys, Artificial / Q000295:instrumentation; D008168:Lung; D008297:Male; D008567:Membranes, Artificial; D008970:Molecular Weight; D009133:Muscular Atrophy / Q000209:etiology; D010243:Paralysis / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000209:etiology / Q000517:prevention & control*; D010539:Permeability; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications
D008567:Membranes, Artificial; D003404:Creatinine